Litcius/Paper detail

Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathy

Agata Grazia D’Amico, Grazia Maugeri, Benedetta Magrì, Claudio Bucolo, Velia D’Agata

2024Experimental Eye Research19 citationsDOIOpen Access PDF

Abstract

Diabetic retinopathy (DR) is a microvascular complication of diabetes characterized by neurovascular impairment of the retina. The dysregulation of the mitophagy process occurs before apoptotic cell death and the appearance of vascular damage. In particular, mitochondrial alterations happen during DR development, supporting the hypothesis that mitophagy is negatively correlated to disease progression. This process is mainly regulated by the PTEN-induced putative kinase protein 1 (PINK1)/Parkin pathway whose activation promotes mitophagy. In this review, we will summarize the evidence reported in the literature demonstrating the involvement of the PINK1/Parkin pathway in diabetic retinopathy-induced retinal degeneration.

Topics & Concepts

MitophagyParkinPINK1Diabetic retinopathyRetinaMedicineDiabetes mellitusRetinopathyBioinformaticsCancer researchDiseaseNeuroscienceBiologyApoptosisInternal medicineEndocrinologyAutophagyGeneticsParkinson's diseaseRetinal Diseases and TreatmentsRetinal Development and DisordersAutophagy in Disease and Therapy